These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23772474)

  • 1. Do elevated hematocrits prolong the PT/aPTT?
    Austin M; Ferrell C; Reyes M
    Clin Lab Sci; 2013; 26(2):89-94. PubMed ID: 23772474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values.
    Marlar RA; Potts RM; Marlar AA
    Am J Clin Pathol; 2006 Sep; 126(3):400-5. PubMed ID: 16880137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of telavancin on coagulation test results.
    Barriere SL; Goldberg MR; Janc JW; Higgins DL; Macy PA; Adcock DM
    Int J Clin Pract; 2011 Jul; 65(7):784-9. PubMed ID: 21564449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of drawing a discard tube on PT and APTT results in healthy adults.
    Bamberg R; Cottle JN; Williams JC
    Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value.
    Kanahara M; Kai H; Okamura T; Wada T; Suda K; Imaizumi T; Sagawa K
    Thromb Res; 2008; 121(6):781-5. PubMed ID: 17904620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of temperature and time before centrifugation of specimens for routine coagulation testing.
    Salvagno GL; Lippi G; Montagnana M; Franchini M; Poli G; Guidi GC
    Int J Lab Hematol; 2009 Aug; 31(4):462-7. PubMed ID: 18371059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
    Peng L; Yan C; Wu X; Nie L
    Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative estimation of preanalytical variables which may influence the determinations of prothrombin time (PT) and activated partial thromboplastin time (APTT)].
    Isa K; Yamauchi MS; Nago TT; Yamane N
    Rinsho Byori; 2010 Oct; 58(10):979-85. PubMed ID: 21077287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
    Peterson P; Gottfried EL
    Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of PT and APTT under excessive anticoagulant in plasma from rats and dogs.
    Kurata M; Noguchi N; Kasuga Y; Sugimoto T; Tanaka K; Hasegawa T
    J Toxicol Sci; 1998 May; 23(2):149-53. PubMed ID: 9644654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect (or lack of it) of severe anemia on PT and APTT results.
    Siegel JE; Swami VK; Glenn P; Peterson P
    Am J Clin Pathol; 1998 Jul; 110(1):106-10. PubMed ID: 9661929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors.
    Niederdöckl J; Dempfle CE; Schönherr HR; Bartsch A; Miles G; Laggner A; Pathil A
    Int J Lab Hematol; 2016 Aug; 38(4):426-34. PubMed ID: 27384253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the minimal citrate tube fill volume for routine coagulation tests on ACL TOP 500 CTS®.
    Ver Elst K; Vermeiren S; Schouwers S; Callebaut V; Thomson W; Weekx S
    Int J Lab Hematol; 2013 Dec; 35(6):614-9. PubMed ID: 23663653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is duplicate testing for prothrombin time and activated partial thromboplastin time necessary?
    Keshgegian AA; Mann JM; Cooper JH
    Arch Pathol Lab Med; 1986 Jun; 110(6):520-2. PubMed ID: 3754725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Low Volume and Conventional Sodium Citrate Tubes for Routine Coagulation Testing.
    Chang SH
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy screening in children with heparinized central venous catheters.
    Ellis MR
    Pediatrics; 1993 Jun; 91(6):1147-50. PubMed ID: 8502518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
    Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
    Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?
    Martinuzzo M; Barrera L; Rodriguez M; D'Adamo MA; López MS; Otaso JC
    Int J Lab Hematol; 2015 Dec; 37(6):853-60. PubMed ID: 26338156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collection of blood specimens by venipuncture for plasma-based coagulation assays: necessity of a discard tube.
    Raijmakers MT; Menting CH; Vader HL; van der Graaf F
    Am J Clin Pathol; 2010 Feb; 133(2):331-5. PubMed ID: 20093244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions.
    Rizzo F; Papasouliotis K; Crawford E; Dodkin S; Cue S
    Res Vet Sci; 2008 Aug; 85(1):166-70. PubMed ID: 17998140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.